Assessment Pembrolizumab (Keytruda): CADTH Reimbursement Advice: Indicator: Together with chemotherapy, with the treatment of adult clients with domestically recurrent unresectable or metastatic triple-negative breast cancer who have not received prior chemotherapy for metastatic illness and whose tumours Specific programmed cell Demise-ligand one (combined favourable rating ≥ 10) as ... https://pembrolizumab-cost72603.blogaritma.com/33950996/keytruda-cost-things-to-know-before-you-buy